Tessa Therapeutics Ltd

Tessa Therapeutics Ltd company information, Employees & Contact Information

Tessa Therapeutics is a clinical-stage biotechnology company developing next-generation cell therapies for the treatment of hematological cancers and solid tumors. Tessa’s autologous CD30-CAR-T therapy TT11, is currently being investigated as a potential treatment for relapsed or refractory classical Hodgkin lymphoma as both a monotherapy (Phase 2) and combination therapy (Phase 1b). TT11 has been granted RMAT designation by the FDA and access to the PRIME scheme by European Medicine Agency. Tessa is also advancing an allogeneic “off-the-shelf” cell therapy platform targeting a broad range of cancers in which Epstein Barr Virus Specific T Cells (EBVSTs) are augmented with CD30-CAR. This platform is currently the subject of a Phase 1 clinical trial in CD30-positive lymphomas. Tessa has its global headquarters in Singapore, where the company has built a state-of-the-art, commercial cell therapy manufacturing facility. For more information on Tessa, visit www.tessacell.com.

Company Details

Employees
40
Address
Depot Road, 138 Depot Road,#07-01,singapore
Phone
(656)384-0755
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
CellVec Pte Ltd.
HQ
Singapore, Central Singapore
Looking for a particular Tessa Therapeutics Ltd employee's phone or email?

Tessa Therapeutics Ltd Questions

News

Tessa Therapeutics dissolves after raising more than $200M - Fierce Biotech

Tessa Therapeutics dissolves after raising more than $200M Fierce Biotech

Tessa Therapeutics Completes US$126 Million Financing Led by Polaris Partners - GlobeNewswire

Tessa Therapeutics Completes US$126 Million Financing Led by Polaris Partners GlobeNewswire

Temasek-backed Tessa Therapeutics to cease operations after failure to raise funding - The Business Times

Temasek-backed Tessa Therapeutics to cease operations after failure to raise funding The Business Times

Tessa Therapeutics’ closure due to increasing interest rate and unsustainable revenue - The Online Citizen

Tessa Therapeutics’ closure due to increasing interest rate and unsustainable revenue The Online Citizen

Singapore’s Tessa Therapeutics raises US$126m led by Polaris Partners - The Business Times

Singapore’s Tessa Therapeutics raises US$126m led by Polaris Partners The Business Times

Tessa Therapeutics appoints ex-Takeda executive as CEO - The Business Times

Tessa Therapeutics appoints ex-Takeda executive as CEO The Business Times

Tessa Therapeutics’ new CEO bullish on moonshot in off-the-shelf cancer therapy - The Business Times

Tessa Therapeutics’ new CEO bullish on moonshot in off-the-shelf cancer therapy The Business Times

Top Tessa Therapeutics Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant